Elisabeth Lundqvist Åvall

Publications
CV
Public outreach and news

Articles

Article: ACTA ONCOLOGICA. 2018;57(3):331-337
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study
Hjerpe E; Staf C; Dahm-Kahler P; Stalberg K; Bjurberg M; Holmberg E; Borgfeldt C; Tholander B; Hellman K; Kjolhede P; Hogberg T; Rosenberg P; Avall-Lundqvist E
Article: QUALITY OF LIFE RESEARCH. 2018;27(1):59-74
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML; GCIG Symptom Benefit group
Article: GYNECOLOGIC ONCOLOGY. 2018;148(1):36-41
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Roncolato FT; Berton-Rigaud D; O'Connell R; Lanceley A; Sehouli J; Buizen L; Okamoto A; Aotani E; Lorusso D; Donnellan P; Oza A; Avall-Lundqvist E; Berek J; Hilpert F; Ledermann JA; Kaminsky MC; Stockler MR; King MT; Friedlander M
Article: ONCOLOGIST. 2017;22(9):1117-1124
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Roncolato FT; Joly F; O'Connell R; Lanceley A; Hilpert F; Buizen L; Okamoto A; Aotani E; Pignata S; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Heitz F; Feeney A; Berton-Rigaud D; Stockler MR; King M; Friedlander M; GCIG Symptom Benefit group
Article: EUROPEAN JOURNAL OF CANCER. 2017;79:81-89
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial
Salehi S; Avall-Lundqvist E; Legerstam B; Carlson JW; Falconer H
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;140(12):2693-2700
Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register studyOn behalf of the Swedish Gynecological Cancer Group
Stalberg K; Kjolhede P; Bjurberg M; Borgfeldt C; Dahm-Kahler P; Falconer H; Holmberg E; Staf C; Tholander B; Avall-Lundqvist E; Rosenberg P; Hogberg T
Article: CLINICAL CANCER RESEARCH. 2017;23(5):1227-1235
Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.
Apellániz-Ruiz M; Tejero H; Inglada-Pérez L; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; Castelo B; Redondo A; García-Donás J; Romero-Laorden N; Sereno M; Merino M; Currás-Freixes M; Montero-Conde C; Mancikova V; Åvall-Lundqvist E; Green H; Al-Shahrour F; Cascón A; Robledo M; Rodríguez-Antona C
Article: BRITISH JOURNAL OF CANCER. 2017;116(4):455-463
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).
Lindemann K; Gibbs E; Åvall-Lundqvist E; dePont Christensen R; Woie K; Kalling M; Auranen A; Grenman S; Hoegberg T; Rosenberg P; Skeie-Jensen T; Hjerpe E; Dørum A; Gebski V; Kristensen G
Article: GYNECOLOGIC ONCOLOGY. 2017;144(1):167-173
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
Dahm-Kahler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjolhede P; Rosenberg P; Stalberg K; Hogberg T; Avall-Lundqvist E
Article: ACTA ONCOLOGICA. 2016;55(11):1285-1293
Defecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors
Lind H; Alevronta E; Steineck G; Waldenstrom A-C; Nyberg T; Olsson C; Wilderang U; Dunberger G; al-Abany M; Avall-Lundqvist E
Article: RADIOTHERAPY AND ONCOLOGY. 2016;120(3):537-541
Time-dependent dose-response relation for absence of vaginal elasticity after gynecological radiation therapy
Alevronta E; Avall-Lundqvist E; al-Abany M; Nyberg T; Lind H; Waldenstrom A-C; Olsson C; Dunberger G; Bergmark K; Steineck G; Lind BK
Article: ONCOTARGET. 2016;7(14):18573-18584
Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
Corvigno S; Wisman GBA; Mezheyeuski A; van der Zee AGJ; Nijman HW; Avall-Lundqvist E; Ostman A; Dahlstrand H
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(1):98-109
Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis
Wangsa D; Chowdhury SA; Ryott M; Gertz EM; Elmberger G; Auer G; Lundqvist EA; Kueffer S; Stroebel P; Schaeffer AA; Schwartz R; Munck-Wikland E; Ried T; Heselmeyer-Haddad K
Article: LAKARTIDNINGEN. 2015;112:DLUI
[Paradigm shift in gynecological cancer].
Åvall Lundqvist E
Article: LAKARTIDNINGEN. 2015;112:DLUH
[Hope for improvement of survival in ovarian cancer].
Högberg T; Bergfeldt K; Borgfeldt C; Holmberg E; Åvall Lundqvist E
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS. 2015;131 Suppl 2:S146-S149
Principles of chemotherapy.
Lundqvist EÅ; Fujiwara K; Seoud M
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS. 2015;131 Suppl 2:S150-S152
Targeted therapy in gynecologic cancers: Ready for prime time?
Seoud M; Lundqvist EÅ; Fujiwara K
Article: ACTA ONCOLOGICA. 2015;54(5):772-779
Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors
Kollberg KS; Waldenstrom A-C; Bergmark K; Dunberger G; Rossander A; Wilderang U; Avall-Lundqvist E; Steineck G
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1693-1699
Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action!
Joly F; McAlpine J; Nout R; Åvall-Lundqvist E; Shash E; Friedlander M; Gynaecologic Cancer InterGroup (GCIG)
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):1686-1692
Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012.
McAlpine JN; Greimel E; Brotto LA; Nout RA; Shash E; Avall-Lundqvist E; Friedlander ML; Joly F; Gynecologic Cancer InterGroup (GCIG)
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(8):1389-1394
Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites
Hjerpe E; Brage SE; Stolt MF; Johansson H; Shoshan M; Avall-Lundqvist E
Article: BMC CANCER. 2014;14:68
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
Lindemann K; Malander S; Christensen RD; Mirza MR; Kristensen GB; Aavall-Lundqvist E; Vergote I; Rosenberg P; Boman K; Nordstrom B
Article: BMC CLINICAL PATHOLOGY. 2013;13(1):30
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.
Hjerpe E; Egyhazi Brage S; Carlson J; Frostvik Stolt M; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: SUPPORTIVE CARE IN CANCER. 2013;21(11):3063-3070
Lower limb lymphedema in gynecological cancer survivors-effect on daily life functioning
Dunberger G; Lindquist H; Waldenstrom A-C; Nyberg T; Steineck G; Avall-Lundqvist E
Article: JOURNAL OF MEDICAL GENETICS. 2013;50(9):599-605
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
Leandro-García LJ; Inglada-Pérez L; Pita G; Hjerpe E; Leskelä S; Jara C; Mielgo X; González-Neira A; Robledo M; Avall-Lundqvist E; Gréen H; Rodríguez-Antona C
Article: ACTA ONCOLOGICA. 2013;52(4):719-726
Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy
Alevronta E; Lind H; Al-Abany M; Waldenstrom A-C; Olsson C; Dunberger G; Mavroidis P; Nyberg T; Johansson K-A; Avall-Lundqvist E; Steineck G; Lind BK
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(3):448-455
HSP60 Predicts Survival in Advanced Serous Ovarian Cancer
Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
Article: JOURNAL OF MEDICAL ETHICS. 2013;39(1):41-45
Cancer survivors' perception of participation in a long-term follow-up study
Dunberger G; Thulin H; Waldenstrom A-C; Lind H; Henningsohn L; Avall-Lundqvist E; Steineck G; Kreicbergs U
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS. 2012;119 Suppl 2:S151-S154
Principles of chemotherapy.
Lundqvist EÅ
Article: ANNALS OF ONCOLOGY. 2012;23(10):2613-2619
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
Lindemann K; Christensen RD; Vergote I; Stuart G; Izquierdo MA; Kaem J; Havsteen H; Eisenhauer E; Ridderheim M; Lopez AB; Hirte H; Aavall-Lundquvist E; Vrdoljak E; Green J; Kristensen GB
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;84(2):428-436
Relative Importance of Hip and Sacral Pain Among Long-Term Gynecological Cancer Survivors Treated With Pelvic Radiotherapy and Their Relationships to Mean Absorbed Doses
Waldenstroem A-C; Olsson C; Wilderaeng U; Dunberger G; Lind H; Alevronta E; al-Abany M; Tucker S; Avall-Lundqvist E; Johansson K-A; Steineck G
Article: BMC CANCER. 2012;12:359
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
Wintzell M; Hjerpe E; Lundqvist EA; Shoshan M
Article: CLINICAL CANCER RESEARCH. 2012;18(16):4441-4448
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.
Leandro-García LJ; Leskelä S; Jara C; Gréen H; Avall-Lundqvist E; Wheeler HE; Dolan ME; Inglada-Perez L; Maliszewska A; de Cubas AA; Comino-Méndez I; Mancikova V; Cascón A; Robledo M; Rodríguez-Antona C
Article: JOURNAL OF PHARMACEUTICAL SCIENCES. 2011;100(10):4205-4209
Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer.
Gréen H; Khan MS; Jakobsen-Falk I; Åvall-Lundqvist E; Peterson C
Article: BRITISH JOURNAL OF CANCER. 2011;105(6):737-745
Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
Lind H; Waldenstrom A-C; Dunberger G; Al-Abany M; Alevronta E; Johansson K-A; Olsson C; Nyberg T; Wilderang U; Steineck G; Avall-Lundqvist E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2011;90(8):917-920
Subspecialist training in surgical gynecologic oncology in the Nordic countries.
Antonsen SL; Avall-Lundqvist E; Salvesen HB; Auranen A; Salvarsdottir A; Høgdall C; Nordic Society of Gynaecological Oncology
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2011;80(4):1171-1180
PAIN AND MEAN ABSORBED DOSE TO THE PUBIC BONE AFTER RADIOTHERAPY AMONG GYNECOLOGICAL CANCER SURVIVORS
Waldenstrom A-C; Olsson C; Wilderang U; Dunberger G; Lind H; al-Abany M; Palm A; Avall-Lundqvist E; Johansson K-A; Steineck G
Article: ACTA ONCOLOGICA. 2011;50(2):233-242
Loose stools lead to fecal incontinence among gynecological cancer survivors
Dunberger G; Lind H; Steineck G; Waldenstrom A-C; Onelov E; Avall-Lundqvist E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(27):4162-4169
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.
du Bois A; Herrstedt J; Hardy-Bessard A-C; Müller H-H; Harter P; Kristensen G; Joly F; Huober J; Avall-Lundqvist E; Weber B; Kurzeder C; Jelic S; Pujade-Lauraine E; Burges A; Pfisterer J; Gropp M; Staehle A; Wimberger P; Jackisch C; Sehouli J
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(20):3323-3329
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
Pujade-Lauraine E; Wagner U; Aavall-Lundqvist E; Gebski V; Heywood M; Vasey PA; Volgger B; Vergote I; Pignata S; Ferrero A; Sehouli J; Lortholary A; Kristensen G; Jackisch C; Joly F; Brown C; Le Fur N; du Bois A
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2010;20(3):449-460
Fecal Incontinence Affecting Quality of Life and Social Functioning Among Long-Term Gynecological Cancer Survivors
Dunberger G; Lind H; Steineck G; Waldenstrom A-C; Nyberg T; al-Abany M; Nyberg U; Avall-Lundqvist E
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(3):606-615
Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls
Dunberger G; Lind H; Steineck G; Waldenstrom A-C; Nyberg T; al-Abany M; Nyberg U; Avall-Lundqvist E
Article: AMERICAN JOURNAL OF PATHOLOGY. 2009;175(6):2637-2645
Fluorescence in Situ Hybridization Markers for Prediction of Cervical Lymph Node Metastases
Wangsa D; Heselmeyer-Haddad K; Ried P; Eriksson E; Schaeffer AA; Morrison LE; Luo J; Auer G; Munck-Wikland E; Ried T; Lundqvist EA
Article: MOLECULAR CANCER THERAPEUTICS. 2009;8(7):1916-1923
Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment
Hernlund E; Hjerpe E; Avail-Lundqvist E; Shoshan M
Article: EUROPEAN JOURNAL OF CANCER. 2009;45(9):1700-1708
EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma
Ryott M; Wangsa D; Heselmeyer-Haddad K; Lindholm J; Elmberger G; Auer G; Lundqvist EA; Ried T; Munck-Wikland E
Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2009;104(2):130-137
Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.
Gréen H; Söderkvist P; Rosenberg P; Mirghani RA; Rymark P; Lundqvist EA; Peterson C
Article: BRITISH JOURNAL OF CANCER. 2008;99(7):1121-1128
Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
Wangsa D; Ryott M; Avall-Lundqvist E; Petersson F; Elmberger G; Luo J; Ried T; Auer G; Munck-Wikland E
Article: BRITISH JOURNAL OF CANCER. 2006;94(11):1683-1689
Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer
Beskow C; Kanter L; Holgersson A; Nilsson B; Frankendal B; Avall-Lundqvist E; Lewensohn R
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2006;16(3):1130-1139
Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls
Bergmark K; Avall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: JOURNAL OF SEX AND MARITAL THERAPY. 2005;31(5):361-383
Synergy between sexual abuse and cervical cancer in causing sexual dysfunction
Bergmark K; Åvall-Lundqvist E; Dickman PW; Steineck G; Henningsohn L
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2005;40(6):654-661
Effect of chemotherapy on circulating gastrointestinal hormone levels in ovarian cancer patients:: Relationship to nausea and vomiting
Hursti TJ; Börjeson S; Hellström PM; Åvall-Lundqvist E; Stock S; Steineck G; Peterson C
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii7-viii12
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
du Bois A; Quinn M; Thigpen T; Vermorken J; Avall-Lundqvist E; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Neijt JP; Oza A; Ozols R; Parmar M; Pecorelli S; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Stuart G; Trimble E; Vasey P; Vergote I; Verheijen R; Wagner U; Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii39-viii42
The Gynecologic Cancer Intergroup (GCIG): history and current status.
Vermorken JB; Avall-Lundqvist E; Pfisterer J; Bacon M; GCIG; AGO-OVAR; ANZGOG; EORTC-GCC; GEICO; GINECO; GOG; JGOG; MRC; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii36-viii38
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
Stuart G; Avall-Lundqvist E; du Bois A; Bookman M; Bowtell D; Brady M; Casado A; Cervantes A; Eisenhauer E; Friedlaender M; Fujiwara K; Grenman S; Guastalla JP; Harper P; Hogberg T; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Oza A; Ozols R; Parmar M; Pfisterer J; Poveda A; Provencher D; Pujade-Lauraine E; Quinn M; Randall M; Rochon J; Rustin G; Sagae S; Stehman F; Trimble E; Thigpen T; Vasey P; Vergote I; Verheijen R; Vermorken J; Wagner U; NCIC-CTG; NSGO; AGO-OVAR; GOG; ANZGOG; EORTC; GEICO; JGOG; GINECO; MRC/NCRI; SGCTG; RTOG; NCI-US
Article: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii30-viii35
Integration of new or experimental treatment options and new approaches to clinical trials.
Quinn M; Pfisterer J; Avall-Lundqvist E; Bookman M; Bowtell D; Casado A; Cervantes A; Grenman S; Harper P; Oza A; Pecorelli S; Pujade-Lauraine E; Trimble E; Vasey P; Wagner U; ANZGOG; AGO-OVAR; NSGO; GOG; EORTC; GEICO; MRC/NCRI; NCIC-CTG; IGCS; GINECO; NCI-US; SGCTG
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 2004;23(3):215-222
Laminin-5 γ2 chain expression facilitates detection of invasive squamous cell carcinoma of the uterine cervix
Stoltzfus P; Salo S; Eriksson E; Aspenblad U; Tryggvason K; Auer G; Avall-Lundqvist E
Article: GYNECOLOGIC ONCOLOGY. 2004;93(2):484-492
A population-based study of cervical carcinoma and HPV infection in Latvia
Silins I; Wang XH; Tadesse A; Jansen KU; Schiller JT; Avall-Lundqvist E; Frankendal B; Dillner J
Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2003;13 Suppl 2:172-177
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
Kristensen GB; Vergote I; Stuart G; Del Campo JM; Kaern J; Lopez AB; Eisenhauer E; Aavall-Lundquist E; Ridderheim M; Havsteen H; Mirza MR; Scheistroen M; Vrdoljak E
Article: GYNECOLOGIC ONCOLOGY. 2002;85(2):333-338
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients
Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2002;81(5):443-450
Patient-rating of distressful symptoms after treatment for early cervical cancer
Bergmark K; Åvall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: LAKARTIDNINGEN. 2000;97(46):5347-5355
[A Swedish study of women treated for cervix cancer. Gynecologic cancer often affects sexuality].
Bergmark K; Lundqvist EA; Steineck G
Article: SUPPORTIVE CARE IN CANCER. 2000;8(5):431-434
Aspects of delayed chemotherapy-induced nausea -: Dexamethasone and adrenal response patterns in patients and healthy volunteers
Lundström S; Fürst CJ; Börjeson S; Steineck G; Ävall-Lundqvist E; Hursti TJ; Peterson C; Fredrikson M
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80:2931-2936
Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis
Silins I; Wang ZH; Åvall-Lundqvist E; Frankendal B; Vikmanis U; Sapp M; Schiller JT; Dillner J
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1999;340(18):1383-1389
Vaginal changes and sexuality in women with a history of cervical cancer
Bergmark K; Åvall-Lundqvist E; Dickman PW; Henningsohn L; Steineck G
Article: EUROPEAN JOURNAL OF CANCER. 1997;33(11):1799-1804
The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma
AvallLundqvist EH; Silfversward C; Aspenblad U; Nilsson BR; Auer GU
Article: CANCER NURSING. 1997;20(4):260-266
Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale
Borjeson S; Hursti TJ; Peterson C; Fredikson M; Furst CJ; AvallLundqvist E; Steineck G
Article: JOURNAL OF MEDICAL VIROLOGY. 1997;52(4):436-440
Human papillomavirus antibody responses among patients with incident cervical carcinoma
Wang ZH; Konya J; AvallLundkvist E; Sapp M; Dillner J; Dillner L
Article: SUPPORTIVE CARE IN CANCER. 1996;4(6):440-446
Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms
Peterson C; Hursti TJ; Borjeson S; AvallLundqvist E; Fredrikson M; Furst CJ; Lomberg H; Steineck G
Article: BRITISH JOURNAL OF CANCER. 1996;74(7):1114-1119
Impact of tumour burden on chemotherapy-induced nausea and vomiting
Hursti TJ; AvallLundqvist E; Borjeson S; Fredrikson M; Furst CJ; Steineck G; Peterson C
Article: ACTA ONCOLOGICA. 1996;35(8):1007-1010
Serum cholesterol and apolipoprotein B levels may reflect disease activity in ovarian cancer patients.
Avall-Lundqvist EH; Peterson CO
Article: ONCOLOGY REPORTS. 1995;2(4):619-623
Serum levels of scc, cea, ca-125 and tpa in the management of cervical-carcinoma.
Avalllundqvist E; Schedvins K; Sjovall K; Eneroth P
Article: CANCER EPIDEMIOLOGY. 1995;19(5):381-393
ASSOCIATION OF SERUM ANTIBODIES AGAINST DEFINED EPITOPES OF HUMAN PAPILLOMAVIRUS L1, E2, AND E7 ANTIGENS AND OF HPV DNA WITH INCIDENT CERVICAL-CANCER
DILLNER L; ZELLBI A; AVALLLUNDQVIST E; HEINO P; EKLUND C; PETTERSSON CA; FORSLUND O; HANSSON BG; GRANDIEN M; BISTOLETTI P; DILLNER J
Show more

All other publications

Review: LAKARTIDNINGEN. 2015;112:DLUF
[Individualized treatment for ovarian cancer may become possible].
Kjölhede P; Dahm-Kähler P; Tholander B; Åvall Lundqvist E
Letter: CLINICAL CANCER RESEARCH. 2015;21(13):3092-3093
Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--letter.
Apellániz-Ruiz M; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Sereno M; García-Donás J; Åvall-Lundqvist E; Gréen H; Brøsen K; Bergmann TK; Rodríguez-Antona C
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S102-S108
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.
Satoh T; Takei Y; Treilleux I; Devouassoux-Shisheboran M; Ledermann J; Viswanathan AN; Mahner S; Provencher DM; Mileshkin L; Åvall-Lundqvist E; Pautier P; Reed NS; Fujiwara K
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9):S117-S122
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Vulvovaginal Melanomas
Leitao MMJ; Cheng X; Hamilton AL; Siddiqui NA; Jurgenliemk-Schulz I; Mahner S; Avall-Lundqvist E; Kim K; Freyer G
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S30-S34
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.
Reed NS; Pautier P; Åvall-Lundqvist E; Choi C-H; du Bois A; Friedlander M; Fyles A; Kichenadasse G; Provencher DM; Ray-Coquard I
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(9 Suppl 3):S26-S29
Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.
Glasspool RM; González Martín A; Millan D; Lorusso D; Åvall-Lundqvist E; Hurteau JA; Davis A; Hilpert F; Kim J-W; Alexandre J; Ledermann JA
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2011;21(4):771-775
Clinical trials in recurrent ovarian cancer.
Friedlander M; Trimble E; Tinker A; Alberts D; Avall-Lundqvist E; Brady M; Harter P; Pignata S; Pujade-Lauraine E; Sehouli J; Vergote I; Beale P; Bekkers R; Calvert P; Copeland L; Glasspool R; Gonzalez-Martin A; Katsaros D; Kim JW; Miller B; Provencher D; Rubinstein L; Atri M; Zeimet A; Bacon M; Kitchener H; Stuart GCE; Gynecologic Cancer InterGroup
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;78(3):S706
Dose and Volume Response of the Sigmoid in Radiotherapy of Gynecological Cancer
Alevront E; Lind H; al-Abany M; Waldenstrom AC; Olsson C; Dunberger G; Johansson KA; Avall-Lundqvist E; Steineck G; Lind BK
Editorial comment: ANNALS OF ONCOLOGY. 2005;16 Suppl 8:viii5-viii6
History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004.
Quinn M; Avall-Lundqvist E; du Bois A; Vermorken J; Parmar M; Pfisterer J; Stuart G; Thigpen T; Neijt J
Letter: GYNECOLOGIC ONCOLOGY. 2003;89(2):339
Letter to the editor -: Reply
Silins I; Åvall-Lundqvist E; Dillner J; Frankendal B

Employments

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2024-2027

Degrees and Education

Docent, Karolinska Institutet, 1998

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI